文献速递临床试验与 GCP流行病学与生物统计

邮寄HPV自采样用于服务不足少数族裔女性宫颈癌筛查:随机对照试验研究方案

Mailed HPV self-sampling for cervical cancer screening among underserved minority women: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2017-01-13

针对海地裔、西班牙裔和非裔美国女性开展随机对照试验,计划纳入600名30至65岁、过去3年未行巴氏涂片者。受试者随机接受社区健康工作者递送或邮寄的HPV自采样,主要结局为入组后6个月内完成自采样。

要点

  • 既往SUCCESS试验显示社区健康工作者递送HPV自采样可提高筛查接受度。
  • 本试验比较社区健康工作者递送与邮寄两种HPV自采样方式。
  • 主要结局为入组后6个月内完成HPV自采样。

核心结论

  • 本试验旨在阐明邮寄方式递送HPV自采样的效力,若有效可能成为服务不足和筛查不足少数族裔群体宫颈癌筛查的成本效益策略。

研究设计与样本

  • 随机对照试验,计划纳入来自南佛罗里达小海地、海厄利亚和南戴德社区的海地裔、西班牙裔和非裔美国女性600名。
  • 纳入标准为30至65岁、过去3年内未行巴氏涂片者,由社区健康工作者招募并完成结构化访谈。
  • 受试者随机分为社区健康工作者递送HPV自采样组(第1组)和邮寄递送HPV自采样组(第2组)。

主要发现

  • 既往SUCCESS试验显示社区健康工作者递送HPV自采样相对于导航至巴氏涂片筛查提高了筛查接受度。
  • SUCCESS试验参与者和社区合作伙伴反馈女性可能偏好通过邮寄递送HPV自采样器,从而无需与社区健康工作者预约。

关键数值与推荐

  • 主要结局为入组后6个月内完成HPV自采样。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Underserved ethnic minority women experience significant disparities in cervical cancer incidence and mortality, mainly due to lack of cervical cancer screening. Barriers to Pap smear screening include lack of knowledge, lack of health insurance and access, and cultural beliefs regarding disease prevention. In our previous SUCCESS trial, we demonstrated that HPV self-sampling delivered by a community health worker (CHW) is efficacious in circumventing these barriers. This approach increased screening uptake relative to navigation to Pap smear screening. SUCCESS trial participants, as well as our community partners, provided feedback that women may prefer the HPV self-sampler to be delivered through the mail, such that they would not need to schedule an appointment with the CHW. Thus, our current trial aims to elucidate the efficacy of the HPV self-sampling method when delivered via mail. DESIGN: We are conducting a randomized controlled trial among 600 Haitian, Hispanic, and African-American women from the South Florida communities of Little Haiti, Hialeah, and South Dade. Women between the ages of 30 and 65 years who have not had a Pap smear within the past 3 years are eligible for the study. Women are recruited by CHWs and complete a structured interview to assess multilevel determinants of cervical cancer risk. Women are then randomized to receive HPV self-sampling delivered by either the CHW (group 1) or via mail (group 2). The primary outcome is completion of HPV self-sampling within 6 months post enrollment. DISCUSSION: Our trial is among the first to examine the efficacy of the mailed HPV self-sampling approach. If found to be efficacious, this approach may represent a cost-effective strategy for cervical cancer screening within underserved and underscreened minority groups. TRIAL REGISTRATION: ClinicalTrials.gov, NCT02202109 . Registered on 9 July 2014.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Kobetz E, Seay J, Amofah A, et al. Mailed HPV self-sampling for cervical cancer screening among underserved minority women: study protocol for a randomized controlled trial. Trials. 2017. PMID: 28086983. doi:10.1186/s13063-016-1721-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。